Characterization of Serum Cytokine Profiles of Patients with Active Lupus Nephritis
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241914883 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Zahrà Rahmé und 11 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Rheumatology, Department of Medicine, University of Padova, 35128 Padova, Italy. Hauptthemen laut MEDLINE: Lupus Nephritis, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gruppo LES Italiano.
Abstract (Originalsprache)
Cytokines contribute to the pathogenesis of lupus nephritis (LN), yet their value as prognostic biomarkers is still debated. We aimed to describe the serum cytokines’ profiles and prospectively assess correlations with disease features and renal response in a multicentric cohort of consecutive adult patients with biopsy-proven active LN. Cytokine associations with clinical and serological data were performed at LN diagnosis (T0), and at 3 (T3) and 6 months (T6) of follow up. Renal response according to EULAR definition was assessed at T3, T6 and T12. BAFF and interleukin (IL)-37 were measured by ELISA; IL-2, IL-10, IL-17A and IL-18 by a bead-based multiplex cytokine assay (Luminex). Thirty-nine patients with active LN (age 40.5 ± 15.6 years; F 71.8%; 84.6% proliferative LN) were enrolled, of whom twenty-nine displayed complete longitudinal records. At T0, we observed higher levels of IL-37 and IL-17 in proliferative vs. non-proliferative LN (IL-37: 0.0510 (0.0110–0.2300) vs. 0.0000 (0.0000–0.0397) ng/mL, p = 0.0441; IL-17: 2.0920 (0.5125–17.9400) vs. 0.0000 (0.0000–0.6025) pg/mL, p = 0.0026, respectively), and positive correlations between IL-10 and 24 h proteinuria (r = 0.416, p = 0.0249) and anti-dsDNA levels (r = 0.639, p = 0.0003). BAFF was higher in patients with low complement (p < 0.0001). We observed a sustained correlation between BAFF and IL-10 throughout T6 (r = 0.654, p = 0.0210). Higher baseline IL-37 and BAFF levels were associated with renal response at T3 and T6, respectively, while baseline IL-18 levels were higher in patients achieving response at T12. Our study highlights the complexity of the cytokine network and its potential value as a marker of active LN and renal response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Rheumatology, Department of Medicine, University of Padova, 35128 Padova, Italy.
- Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padova, 35128 Padova, Italy.
- Veneto Institute of Oncology IOV-IRCCS, 35128 Padova, Italy.
- Oncology Referral Center of Aviano (CRO)-IRCCS, 33081 Aviano, Italy.
- Nephrology and Dialysis Unit, San Paolo Hospital, 20153 Milan, Italy.
- Nephrology and Dialysis Division, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.
ORCID-Profile: Chiara Franco, Stefano Realdon, Giulia Frontini, Andrea Doria, Mariele Gatto
Förderung
- Gruppo LES Italiano
Zitieren
APA
Rahmé, Z., Franco, C., Cruciani, C., Pettorossi, F., Zaramella, A., Realdon, S., Iaccarino, L., Frontini, G., Moroni, G., Doria, A., Ghirardello, A., & Gatto, M. (2023). Characterization of Serum Cytokine Profiles of Patients with Active Lupus Nephritis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241914883
Vancouver
Rahmé Z, Franco C, Cruciani C, Pettorossi F, Zaramella A, Realdon S, et al. Characterization of Serum Cytokine Profiles of Patients with Active Lupus Nephritis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241914883
BibTeX
@article{Rahm2023,
author = {Rahmé, Zahrà and Franco, Chiara and Cruciani, Claudio and Pettorossi, Federico and Zaramella, Alice and Realdon, Stefano and Iaccarino, Luca and Frontini, Giulia and Moroni, Gabriella and Doria, Andrea and Ghirardello, Anna and Gatto, Mariele},
title = {Characterization of Serum Cytokine Profiles of Patients with Active Lupus Nephritis},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241914883}
}
EUVIMED